Standards in dementia care
SIR—I read with interest the book review by D. Jolley [1] about Standards in Dementia Care edited by Alistair Burns in the March issue. The publication was done by the European Dementia Consensus Network (EDCON) [2] and was sponsored by the Madariaga European Foundation [3] and co-sponsored by Janssen–Cilag [2], a manufacturer of an anti-dementia drug. In the book review and also on the websites there is no information about the role of sponsoring and no declarations of possible conflicts of interest. While pharmaceutical sponsorship is widespread and influences reported study outcome [4, 5] and the content of medical journals in general [6, 7], I want to address the topic that even the relationships of researchers and physicians in expert boards have to be clarified [8–10]. Without a transparent politic of conflicts of interest, the reader may not recognise the possible influence of industrial sponsors.
Klinik fuer Geriatrie, Krankenhaus Lindenbrunn, Lindenbrunn 1, D-31863 Coppenbruegge, Germany
Tel: 0049-5163-782-295; Fax: 0049-5163-782-287 Email: gogol{at}krankenhaus-lindenbrunn.de
References
- Jolley D. Standards in dementia care. Book review. Age Ageing (2007) 36:236–7.
[Free Full Text] - EDCON. http://www.madariaga.org/template_subpage.asp?pag_id=15&spa_id=34&lng_iso=EN (Access 08.04.2007).
- Madariaga European Foundation. http://www.madariaga.org/ (Access 08.04.2007).
- Lexchin J, Bero LA, Djulbegovic B, et al. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ (2003) 326:1167–70.
[Abstract/Free Full Text] - Bhandari M, Busse JW, Jackowski D, et al. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. CMAJ (2004) 170:477–80.
[Abstract/Free Full Text] - Lexchin J, Light DW. Commercial influence and the content of medical journals. BMJ (2006) 332:1444–7.
[Free Full Text] - Smith R. The trouble with medical journals. J R Soc Med (2006) 99:115–9.
[Free Full Text] - Camphell EG, Weissmann JS, Vogeli C, et al. Financial relationships between institutional review board members and industry. N Engl J Med (2006) 355:2321–9.
[Abstract/Free Full Text] - Lurie P, Almeida CM, Stine N, et al. Financial conflict of interest disclosure and voting patterns at food and drug administration drug advisory committee meetings. JAMA (2006) 295:1921–8.
[Abstract/Free Full Text] - Brennan TA, Rothmann DJ, Blank L, et al. Health industry practises that create conflicts of interest. JAMA (2006) 295:429–33.
[Abstract/Free Full Text]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||